European public biotechnology companies by focus area 2015

Share of the focus area of European public biotechnology companies in 2015

by Statista Research Department, last edited Jan 20, 2015
European public biotechnology companies by focus area 2015 This statistic shows the focus area of European public biotechnology companies in 2015. The majority of companies have a biopharma focus with 79.3 percent of biotechnology firms having a focus on health and/or medicine.
Show more

Share of the focus area of European public biotechnology companies in 2015

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Biotechnology Industry in Europe
Biotechnology Industry in Europe

All Information
in one Presentation

Biotechnology Industry in Europe

Everything On "Biotechnology Industry in Europe" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Biotechnology Industry in Europe"
  • Overview
The most important statistics
  • Research and Development
  • Financing and mergers
  • Patents
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.